Literature DB >> 9132096

Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications.

K L Verstraete1, H J Van der Woude, P C Hogendoorn, Y De-Deene, M Kunnen, J L Bloem.   

Abstract

The purpose of this article is to review the basic principles and clinical applications of dynamic contrast-enhanced MRI in the musculoskeletal system. This method of physiologic imaging provides clinically useful information by depicting tissue vascularization and perfusion, capillary permeability, and composition of the interstitial space. Different imaging, evaluation, and postprocessing techniques are described. The most important applications in the musculoskeletal system are identification of areas of viable tumor for biopsy, tissue characterization, and monitoring of preoperative chemotherapy. Practical guidelines for performing a dynamic contrast-enhanced MR examination are proposed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9132096     DOI: 10.1002/jmri.1880060210

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  23 in total

1.  Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.

Authors:  C Baunin; G Schmidt; K Baumstarck; C Bouvier; J C Gentet; A Aschero; A Ruocco; B Bourlière; G Gorincour; C Desvignes; N Colavolpe; G Bollini; P Auqier; P Petit
Journal:  Skeletal Radiol       Date:  2012-02-09       Impact factor: 2.199

2.  Differentiation of normal and neoplastic bone tissue in dynamic gadolinium-enhanced magnetic resonance imaging: validation of a semiautomated technique.

Authors:  F D'Agostino; P Dell'Aia; C C Quattrocchi; R Del Vescovo; R Setola; R F Grasso; B Beomonte Zobel
Journal:  Radiol Med       Date:  2010-06-24       Impact factor: 3.469

3.  Dynamic contrast-enhanced perfusion MR imaging of diseased vertebrae: analysis of three parameters and the distribution of the time-intensity curve patterns.

Authors:  Osamu Tokuda; Noriko Hayashi; Koutarou Taguchi; Naofumi Matsunaga
Journal:  Skeletal Radiol       Date:  2005-08-10       Impact factor: 2.199

Review 4.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

5.  Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications.

Authors:  Atin Saha; Kyung K Peck; Eric Lis; Andrei I Holodny; Yoshiya Yamada; Sasan Karimi
Journal:  Spine (Phila Pa 1976)       Date:  2014-11-15       Impact factor: 3.468

6.  In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.

Authors:  F Russo; S Mazzetti; G Grignani; G De Rosa; M Aglietta; G C Anselmetti; M Stasi; D Regge
Journal:  Eur Radiol       Date:  2011-12-04       Impact factor: 5.315

7.  Dynamic MRI and fine needle aspiration cytology in the evaluation of soft tissue lesions.

Authors:  Hildur Einarsdóttir; Veli Söderlund; Lambert Skoog; Henrik C F Bauer
Journal:  Skeletal Radiol       Date:  2003-06-26       Impact factor: 2.199

Review 8.  Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.

Authors:  Hervé Brisse; Liliane Ollivier; Véronique Edeline; Hélène Pacquement; Jean Michon; Christophe Glorion; Sylvia Neuenschwander
Journal:  Pediatr Radiol       Date:  2004-04-22

9.  Imaging spectrum in soft tissue sarcomas.

Authors:  Pallavi Aga; Ragini Singh; Anit Parihar; Umesh Parashari
Journal:  Indian J Surg Oncol       Date:  2011-12-10

10.  Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma.

Authors:  T De Coninck; L Jans; G Sys; W Huysse; T Verstraeten; R Forsyth; B Poffyn; K Verstraete
Journal:  Eur Radiol       Date:  2013-06-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.